“Budget Impact Analysis of the Use of Daclatasvir in Italy for the Treatment of Hepatitis C Virus (HCV) Genotype 3 Patients”. 2016. Farmeconomia. Health Economics and Therapeutic Pathways 17 (1): 7-12. https://doi.org/10.7175/fe.v17i1.1225.